Concepedia
Statistics
Publications
31
Citations
2.8K
H-Index
25
Active since
1979
Affiliations
Uppsala University Hospital(Current)
Active Biotech (Sweden)
KTH Royal Institute of Technology
Karolinska University Hospital
Sophiahemmet Hospital
Mats Inganäs is an author at Uppsala University Hospital specializing in medicine, pathology, and oncology.
Top concepts
MedicinePathologyOncologyCancer GeneticsTumor BiologyImmunologyBreast CancerEngineeringCancer ResearchRadiation Oncology
Publications per year
1979–2010
The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus Immunohistochemistry
S. Sjögren, Mats Inganäs, Torbjörn Norberg et al. · JNCI Journal of the National Cancer Institute · 1996 · 387 citations · Full text
Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers.
S. Sjögren, Mats Inganäs, A. Lindgren et al. · Journal of Clinical Oncology · 1998 · 330 citations
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.
E. Berns, John A. Foekens, R. van Vossen et al. · PubMed · 2000 · 197 citations
Breast Oncology, Pathology, Complete Sequencing +19
Chimeric IgG-binding receptors engineered from staphylococcal protein A and streptococcal protein G.
Margareta Eliasson, Anders Olsson, Elisabeth Palmcrantz et al. · Journal of Biological Chemistry · 1988 · 179 citations · Full text
Immunology, Molecular Biology, Antigen Processing +19
A follow‐up study of children with food allergy. Clinical course in relation to serum IgE‐ and IgG‐antibody levels to milk, egg and fish
A Dannaeus, Mats Inganäs · Clinical & Experimental Allergy · 1981 · 170 citations
1–5 of 31